China BioMed Innovation and Investment Conference (CBIIC) was established on November 14, 2016 by China Pharmaceutical Innovation and Research Development Association (PhIRDA), China Association for Medical Devices Industry (CAMDI) and Hong Kong Exchange and Clearing Limited (HKEX). Aiming to build an authorized platform of collaboration and integration for pharmaceutical innovative enterprises, investors and capital at home and abroad, CBIIC has drawn more than 3500 participants, over 700 pharmaceutical industries and 500 financial institutions, including government officials, senior executives and experts in pharmaceutical industry and representatives from media.